Skip to main content
Premium Trial:

Request an Annual Quote

Hologic Gains CE Mark for Aptima HCV Assay

NEW YORK (GenomeWeb) – Hologic today announced it has earned CE-IVD certification for its Aptima hepatitis C virus (HCV) Quant Dx assay.

The transcription-mediated amplification-based assay, which runs on the Panther system, is certified both to confirm active infection in patients with a positive antibody result and to monitor viral load. The firm said in a statement that the assay's limit of detection is 4.3 IU/mL in plasma and 3.9 IU/mL in serum, and its lower limit of quantitation is 10 IU/mL.

In December 2014, Hologic's Aptima HIV-1 assay received the CE Mark. The firm noted that its Aptima HCV and HIV-1 assays are not approved for use in the US.

The Scan

Taking Stock of the Stockpile

The US and European countries are evaluating their smallpox vaccine stockpiles as the number of monkeypox cases increases, the Washington Post reports.

Vitamin D From Tomatoes

According to Reuters, researchers in the UK have gene-edited tomatoes so their fruit contains vitamin D.

Cause Not Yet Spotted

NPR reports that a new study was unable to find a cause for persistent long COVID symptoms.

PNAS Papers on Central African Hunter-Gatherers, Myopia Development, Ancient Microtia Allele

In PNAS this week: population patterns among Central African hunter gatherers, effect of myopia-linked gene variant, and more.